ABSTRACT Respiratory symptoms and lung function were studied in nine coffee workers who complained of job related respiratory symptoms. Six described symptoms characteristic of occupational asthma. Lung function data showed obstructive changes mostly in the smaller airways with no impairment in diffusing capacity. Bronchoprovocation testing with green coffee allergen provoked immediate asthmatic reactions with acute reductions of ventilatory capacity in four workers. The relative fall in FEF2575% (ranging from 28% to 66%) was greater than in FEV1 (ranging from 18% to 62% of the control values). Eight of the nine workers had an increased total IgE serum level; five had positive intradermal skin tests to green coffee allergen. Most of the six healthy subjects experimentally exposed to green coffee dust in the working environment showed an acute fall in flow rates on maximum expiratory flow-volume curves. These results indicate that bronchoprovocation with green coffee allergen or green coffee dust may be used to identify subjects sensitive to green coffee.
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Asthma or other allergic symptoms in coffee workers have been described by several authors suggesting a reagin mediated reaction to inhaled green coffee. ' -5 In our epidemiological studies of the effect of coffee dust on respiratory function in coffee workers we found that several coffee processors complained of respiratory symptoms accompanied by acute or chronic changes in lung function.67 Somazi and Wutrich showed an acute decrease in lung function after the inhalation of green coffee allergen,8 and Karr et al reported a fall in FEV, in two subjects after a bronchial provocation challenge with green coffee beans.5 Experimental studies with green and roasted coffee allergen on isolated guinea pig tracheal smooth muscle have indicated a bronchoconstrictive effect of green coffee dust.9
In the present investigation lung function measurement and bronchial provocation testing with green coffee dust allergen were performed in coffee workers who complained of respiratory difficulties during the working shift. In addition, we studied acute lung function changes in healthy volunteers experimentally exposed to green coffee dust in the working environment. wheezing, and shortness of breath during exposure to dust at work.
The workers were also asked about allergic symptoms with specific emphasis on the intensity of such problems related to coffee dust exposure.
Lung function measurement Ventilatory capacity was measured by recording the forced expirogram from which the forced vital capacity (FVC), forced expiratory volume in one second (FEV,), and maximum mid-expiratory flow (MMEF) rates between 25% and 75% of the FVC (FEF2$.75%) were read. In addition, maximum expiratory flow volume (MEFV) curves were recorded with a Pneumoscreen (Jaeger, West Germany). Flow rates at 50% and the last 25% of the vital capacity (MEF50% and MEF25%) were determined from the MEFV curves. Functional residual capacity (FRC), residual volume (RV), and total lung capacity (TLC) were measured with a spirometer Pulmotest (Gould, Godart, Netherlands). Diffusing capacity (DLco) was measured by the single breath method with a Resparameter (Morgan Ltd, England). To study the effect of a bronchodilator, the MEFV curves were repeated after inhalation of two puffs of bromhexine/ orciprenaline (Alupent).
The measured values were compared with the expected normal values of CECA" for FVC, FEV,, and RV, of Morris et al for FEF2^_75%,'2 of Cherniack and Raber for MEF50% and MEF25%,'3 and of Cotes for DLco. '4 Immunological studies
The workers were skin tested with aqueous extracts of green coffee and roasted coffee using the standard intradermal test. Coffee allergens were prepared from green and roasted coffee dust collected in the coffee industry in which the subjects were employed. In addition, intracutaneous testing was made with histamine base (0.1 mg/ml) and buffer as control solutions. Intradermal skin tests with these allergens were performed using a dilution of 1:500 (0-02 ml of solution). The skin reactions were read after 20 minutes and were considered positive if the diameter of the weal was larger than 9 mm. '5 Serum levels of total IgE antibody were measured by PRIST (Pharmacia Diagnostics AG, Uppsala, Sweden), a direct radioimmunological sandwich technique based on paper discs as the solid phase; '6 An IgE level below 125 IU/ml was considered as normal (Behringwerke AG, Marburg-Lahn).
Bronchial provocation testing The bronchial inhalation challenge was performed with an aqueous extract of green coffee allergen. Before the challenge all subjects were clinically normal and had normal ventilatory capacity. Bronchial challenge was also performed with physiological saline as a control; 1 ml of physiological saline was placed in a Heyer Piccolo nebuliser (Carl Heyer GmbH, Bad Ems, West Germany) which, with an air flow of 15 /min nebulised the fluid during inspiration only. If no response occurred to the inhalation of the placebo the procedure was repeated with 1 ml of aqueous extract of green coffee allergen. The subjects were asked to inhale the whole amount of the solution (green coffee allergen or a placebo). The dose of green coffee allergen was determined on the basis of the reaction to the skin prick tests with the aqueous extract of green coffee allergen in a dilution 1:500. A weal of greater than 3 mm was considered to be a positive reaction. '7 All workers were challenged with green coffee allergen in a concentration of 1:500.
Ventilatory function testing was performed before exposure and at 5, 10, and 20 minutes after the cessation of exposure. A positive response was defined as a 20% fall in FEV, and a 25% fall in FEF2s 75% from the baseline after antigen challenge.
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Bronchial reactivity in green coffee exposure Immunological studies Positive intradermal skin tests to green coffee allergen were found in six workers; one only had a positive skin reaction to roasted coffee (table 1) .
In eight of the nine coffee workers the IgE level in the serum was considerably higher than normal (range: 148-1000 IU/ml) (table 1).
Bronchial provocation testing Four of the nine workers showed a considerable decrease of ventilatory capacity at five and 10 minutes after inhaling green coffee (fig). These four complained of upper and lower respiratory symptoms at work and they had a positive skin prick test and serum IgE levels ranging from 235 to 750 IU/ ml. Acute reductions in FEV1 varied from 18% to 43% at five minutes and from 24% to 62% at 10 minutes after inhalation. Acute reductions in 
Bronchial reactivity in green coffee exposure MEF2575% were larger, varying from 28% to 51% at five minutes and from 50% to 66% at 10 minutes after coffee challenge. Ten minutes after the inhaling the green coffee allergen, two subjects were given bromhexine/orciprenaline (Alupent) and one subject was given parenteral aminophylline. Subject PM who had the largest acute reductions was followed up for 24 hours. No late reaction was noted, and at 24 hours lung function was within normal limits.
EXPERIMENTAL EXPOSURE IN HEALTHY SUBJECTS
Lung function measurement In the six healthy sujects who were experimentally exposed to green coffee dust ( Environmental measurements Dust concentrations of green coffee during the experimental exposures were: mean total dust 5 6 mg/m3 and respirable dust, 0-7 mg/m3.
Discussion
The present study indicates that exposure to dust during coffee processing is likely to cause the development of chronic respiratory symptoms and changes in lung function in coffee workers. These data are in agreement with our previous epidemiological investigation of coffee workers in which we showed a significantly higher prevalence of chronic respiratory symptoms in exposed workers compared with a non-exposed referent group.67 All nine workers included in the present study complained of occupational allergic manifestations, such as rhinitis, expiratory dyspnoea, conjuctivitis, or headache shortly after starting work. They all noted an improvement in their symptoms when not working, particularly at weekends and during vacations. Two workers reported the onset of wheezing soon after starting work in the coffee industry.
In our study the provocative inhalation of a green coffee allergen caused bronchoconstriction in four of the nine workers tested. They showed an immedi-419 ate reaction, none showed a late reaction. Karr et al and Karr found a significant immediate asthmatic reaction in two skin test and RAST positive subjects after provocative inhalation challenge with green coffee dust.5 18 The authors failed, however, to produce an airway response in a skin and RAST negative asthmatic subjects.
The effect of coffee allergen in our workers was particularly noticeable on flow rates at low lung volumes. The FEF2575% was a more sensitive test than the FEV, in detecting broncho-obstructive changes after provocative inhalation challenge with the green coffee allergen. Such a pattern of airways constriction suggests that the small airways are primarily affected in the response. Similar results were observed in inhalation studies with aqueous extracts of cotton dust'9 or hemp dust20 indicating that changes in the flow rates on maximum or partial expiratory flow volume curves are more sensitive than the FEVI in detecting the acute effects of such agents. No changes in diffusing capacities were found in our workers, although we had studied workers exposed both for long periods (14 to 17 years) and short periods (3 and 4 years).
All the workers with positive bronchial provocation test had positive skin reaction to green coffee. These results indicate that skin reactions to green coffee allergen have a great specificity for detecting workers sensitive to green coffee. In all the workers with positive bronchoprovocation tests, the IgE levels were above the normal values.
The experimental study with six volunteers suggested that even a short exposure (45 minutes) to green coffee dust may cause an acute reduction in flow rate. Four of the six subjects complained of chest tightness and difficulty in breathing during exposure.
An aqueous extract of green coffee produced contraction in smooth muscle isolated from the trachea of guinea pigs whereas an extract of roasted coffee did not.2' Such data suggest that extracts of coffee dust have a biological activity that changes from a contractile to a relaxant effect as a consequence of processing. Osterman et al reported that raw coffee bean dust seems to have moderately potent allergen. 22 The same authors emphasised the importance of atopic status, degree and duration of exposure and smoking habit as predisposing factors in the development of sensitivity to coffee bean dust.
Our study indicates that occupational challenge tests, skin tests, and the serum reagin titre are important in determining the sensitivity of airways to green coffee allergen. Such tests should be used in medical examinations as a means by which to identify workers sensitive to coffee dust. Atopic workers or those with non-specific bronchial hyperreactivity should be followed up and, if their lung function becomes impaired or they develop respiratory symptoms, they should be moved to another job.
